Acquirer | Target | Price |
---|---|---|
Baxalta Inc. | Collaboration on CAR T cell therapies | $105 million |
ResMed Inc. | Brightree | $800 million |
Amgen | Rights to wearable drug injectors | $55 million |
Recipharm AB | Mitim Srl | $74.7 million |
McKesson Corporation | 2 oncology companies | $1.2 billion |